Analysis of Preclinical Brain Imaging Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
According to the new market research report by Fact.MR, the global preclinical brain imaging market is analyzed to touch US$ 4.57 billion in 2025. Demand is evaluated to rise at 7.4% CAGR to reach a valuation of US$ 9.33 billion by the end of 2035.
The market for preclinical brain imaging is driven by the rising incidence of neurological conditions, such as epilepsy, Parkinson's disease, Alzheimer's, and other diseases. Early-stage brain imaging aids in the development of more potent treatments and improves our understanding of the mechanisms underlying these illnesses.
Higher resolution, better contrast, and more in-depth understandings of brain anatomy and function have resulted from ongoing advancements in imaging modalities, including MRI, PET, and optical imaging. These developments are making it possible for scientists to investigate neurological disorders more precisely at the molecular and cellular levels.
Pharmacies, governments, and commercial organizations are all making significant investments in neuroscience research. This funding is facilitating the creation of advanced preclinical imaging technologies, giving researchers the tools they need to better understand the intricacies of the brain and enhance drug discovery procedures.
North America is projected to hold a leading position with 34.3% of the global market share in 2025. The market in this region is expanding due to the growing investment in healthcare technologies and the rising collaboration between biotechnology, businesses, and research institutions. Adoption of preclinical brain imaging systems is increasing due to the growing emphasis on developing personalized medicine and early neurological problem identification.
Based on imaging type, the demand for magnetic resonance imaging (MRI) is estimated to reach US$ 1.86 billion in 2025 as it is producing high-resolution and non-invasive images of the structure and function of the brain. MRI is perfect for researching neurological conditions, such as Alzheimer's disease, Parkinson's disease, and brain malignancies because it provides exceptional contrast resolution for soft tissues. This technique is also a desirable solution for preclinical brain research as it produces detailed three-dimensional images without the use of dangerous radiation.
| Report Attribute | Detail |
|---|---|
| Preclinical Brain Imaging Market Size (2025E) | US$ 4.57 Billion |
| Forecasted Market Value (2035F) | US$ 9.33 Billion |
| Global Market Growth Rate (2025 to 2035) | 7.4% CAGR |
| North America Market Share (2025E) | 34.3% |
| East Asia Market Value (2025E) | US$ 806.99 Million |
| South Asia & Pacific Market Growth Rate (2025 to 2035) | 8.9% CAGR |
| Magnetic Resonance Imaging (MRI) Segment Value (2035F) | US$ 3.76 Billion |
| Foil Segment Value (2035F) | US$ 4.26 Billion |
| Key Companies Profiled | Pure Imaging Phantoms; Bruker Corporation; Mediso Ltd.; Spectral Instruments Imaging; SIMTICS Ltd.; Biodex Medical Systems, Inc.; MR Solutions; Aspect Imaging; TriFoil Imaging; Caliber Imaging & Diagnostics, Inc. |
Preclinical imaging is a technique used to monitor animals for research purposes, such as in new drug development. Preclinical imaging includes different imaging modalities, in which only some are suitable for imaging small animals, and others are used in large animals. Preclinical imaging is used by researchers in visualizing changes in animal’s molecular, tissue and organ system.
Preclinical brain imaging is a method to scan and visualize the neurological activity during preclinical study. Preclinical brain imaging is categorized into structural imaging and functional imaging. Structural brain imaging scans the structure of large intracranial organs and functional imaging is majorly used in diagnosis of metabolic disorders.
Preclinical brain imaging modalities with non-invasive imaging techniques, such as position emission tomography (PET) and single photon emission computed tomography (SPECT) are used for this purposes. The technique is further used to observe the treatment response for early signals, as stated in the preclinical brain imaging industry analysis.
Preclinical brain imaging is done using advanced high frequency ultrasound by using techniques, such as Computed tomography (CT) and Magnetic resonance imaging (MRI). The most used preclinical brain imaging technique is PET+CT (x-ray computed tomography). Certain advanced integrated systems that includes multiple functionalities, for instance, molecular and structural imaging are in increased demand.
Due to technological advancements, the companies are constantly upgrading their product offerings, for instance, Medisco Ltd. has launched integrated preclinical whole body PET/ MRI system, which has multi-cell anesthesia imaging bed and high throughput screening, and easy installation makes it popular among the users.
PET-CT preclinical imaging device is used in nuclear medicine procedures for detecting brain tumor, brain disorders, Alzheimer’s and other diseases. This preclinical brain imaging method also determine the effectivity of the drug treatment and reduces the need for unnecessary surgical procedures as the preclinical brain imaging scanner determine the tissue mass.
The advance features of the new age imaging devices have increased their adoption, according to the preclinical brain imaging industry outlook. Among the end users, the pharmaceutical companies and CRO segments are evaluated to hold significant shares in the global market.
According to a report of the National Brain tumor Society it is estimated that nearly 700,000 Americans are living with a brain tumor and cases of brain tumor will increase gradually. The growing prevalence of brain cancer all around the globe laterally with increasing incidence rate of neurodegenerative disorders is driving the growth in the global market.
Due to technological advancements players are majorly focusing on product innovation for improving product portfolio, which creates growth opportunities for them in the market. Increase in R&D activities and rising governmental funding for research purposes are stimulating market growth, according to the preclinical brain imaging industry analysis. However, the high cost of the imaging technique is one of the major restraining factors in the growth of the global market.
Geographically, North America is projected to be the dominant regional market, as stated in the preclinical brain imaging industry outlook. The region will be followed by South Asia & Pacific due to growing health care awareness among population and rincreasing R&D activities.
Examples of some of the key players operating in the global market are Pure Imaging Phantoms, Bruker Corporation, Mediso Ltd., Spectral Instruments Imaging, SIMTICS Ltd., Biodex Medical Systems, Inc., MR Solutions, Aspect Imaging, TriFoil Imaging, and Caliber Imaging & Diagnostics, Inc., among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
What is driving the preclinical brain imaging market growth?
The growing prevalence of brain cancer laterally with increasing of neurodegenerative disorders are driving market growth.
Who are the key players in the preclinical brain imaging market?
Some of the key players operating in the global market are Pure Imaging Phantoms, Bruker Corporation, Mediso Ltd., and TriFoil Im.
Table 01: Global Market US$ Mn Forecast by Region
Table 02: Global Market US$ Mn Forecast by Imaging Type
Table 03: Global Market US$ Mn Forecast by End User
Table 04: North America Market US$ Mn Forecast by Country
Table 05: North America Market US$ Mn Forecast by Imaging Type
Table 06: North America Market US$ Mn Forecast by End User
Table 07: Latin America Market US$ Mn Forecast by Country
Table 08: Latin America Market US$ Mn Forecast by Imaging Type
Table 09: Latin America Market US$ Mn Forecast by End User
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Imaging Type
Table 12: Western Europe Market US$ Mn Forecast by End User
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Imaging Type
Table 15: Eastern Europe Market US$ Mn Forecast by End User
Table 16: Asia Pacific Market US$ Mn Forecast by Country
Table 17: Asia Pacific Market US$ Mn Forecast by Imaging Type
Table 18: Asia Pacific Market US$ Mn Forecast by End User
Table 19: East Asia Market US$ Mn Forecast by Country
Table 20: East Asia Market US$ Mn Forecast by Imaging Type
Table 21: East Asia Market US$ Mn Forecast by End User
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Imaging Type
Table 24: MEA Market US$ Mn Forecast by End User
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 04: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 05: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 07: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 08: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 09: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 17: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 18: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 20: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Imaging Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Preclinical Brain Imaging Market